Trial intelligence / Profile preview

Oral Nitrite in Metabolic Syndrome and Hypertension

NCT01681810Phase 2Completed

Start
Oct 2012
Primary completion
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium nitrite in metabolic syndrome, hypertension (HTN). Started Oct 2012; status: completed.

02

Drugs

sodium nitrite
03

Conditions

metabolic syndromehypertension (HTN)

Beyond the preview

Go deeper on NCT01681810.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01681810.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call